KGC researchers work on developing red ginseng oil products at its lab in South Korea. The firm said that the products were found to be effective in dealing with prostatic hyperplasia. Photo courtesy of KGC

KGC, Suwon University scientists carry out in vivo tests

A team of South Korean scientists announced on March 22 that red ginseng oil was found to be quite effective in dealing with benign prostatic hyperplasia.

The team, which is headed by researchers at Korea Ginseng Corporation (KGC) and Suwon University, came up with the conclusion after working on red ginseng oil extract.

Red ginseng oil was obtained from red ginseng marc, the byproduct generated during the traditional procedures of cranking out red ginseng.

Thus far, red ginseng marc has been discarded, but the KGC and Suwon University team discovered the various health benefit of the substance.

In particular, red ginseng oil can grapple with abnormal proliferation of the prostate, which frequently occurs in middle-aged men, the team found.

According to the Health Insurance Review and Assessment Service, up to 1.35 million people visited hospitals in 2021 due to problems with their prostate.

More than 90 percent of them were man aged 50 or older, the state-run agency noted. But recently, youngsters who suffer from the problems have been on the increase.

“The research team divided benign prostatic hyperplasia-induced rates into five groups to administer different amounts of red ginseng oils for eight weeks,” a KGC official said.

“The in vivo study showed that red ginseng oil substantially reduced prostate weight by around 20 percent. The results suggest that red ginseng oil may inhibit the development of benign prostatic hyperplasia.”

Korea’s red ginseng has been widely used for the restoration of health and prevention of diseases for people.

But this marks the first time that it and its byproducts can have benefits for prostatic hyperplasia.